Autologous Serum 20% ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 53 | Sjogren syndrome | 1 |
53. Sjogren syndrome
Clinical trials : 283 / Drugs : 320 - (DrugBank : 101) / Drug target genes : 56 - Drug target pathways : 181
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03436576 (ClinicalTrials.gov) | September 12, 2018 | 12/2/2018 | Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye | Comparison of Autologous Serum 20% and Autologous Serum 50% for the Treatment of Severe Dry Eye | Dry Eye;Keratoconjunctivitis Sicca;Sjogren's Syndrome;Corneal Diseases;Conjunctival Diseases;Keratitis;Lacrimal Apparatus Diseases | Drug: Autologous Serum 20%;Drug: Autologous Serum 50% | Pontificia Universidad Catolica de Chile | Hospital Dr Sotero del Rio | Unknown status | 18 Years | N/A | All | 20 | Phase 3 | Chile |